MD Anderson | GenomeWeb

MD Anderson

The companies will work together to advance the use of ApoCell's rare cell isolation platform for cancer molecular profiling and monitoring in clinical trials.

The centers will support the NCI's Genomic Data Analysis Network, which is tasked with creating tools and strategies to study large-scale genomics data.

The center plans to recruit and analyze samples from about 2,000 patients participating in solid tumor clinical trials in MD Anderson's Moon Shots program.

Single nucleus sequencing analysis of triple-negative breast tumors indicated that copy number changes occur in bursts early in tumor evolution.

Researchers saw abbreviated overall survival times in estrogen receptor-positive metastatic breast cancer patients with ESR1 mutations in their cell-free DNA.

The partners will investigate new strategies for using two of drugmaker's immuno-oncology agents to treat early- and advanced-stage lung cancer.

Researchers find different molecular signatures in cancers from men as compared to those from women, the Wall Street Journal reports.

In individuals at risk of colorectal cancer, pre-cancerous adenomas contain somatic mutations affecting known cancer genes and pathways.

Researchers also found that higher frequencies of BRAF V600E mutations in the blood were associated with poorer outcomes and less responsiveness to BRAF inhibitors.

Researchers compared precision and non-precision approaches in 346 Phase I studies, and found that personalized medicine improves patient outcomes.


In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.